Tessera Therapeutics, Cambridge, MA

Tessera Therapeutics

www.tesseratherapeutics.com

Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and clinicians the ability to write therapeutic messages into the human genome, thereby curing diseases at their source. The GENE WRITING platform allows the correction of single nucleotides, the deletion or insertion of short sequences of DNA, and the writing of entire genes into the genome, offering the potential for a new category of genetic medicines with broad applications both in vivo and ex vivo. Tessera Therapeutics was founded by Flagship Pioneering in 2018, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies ...

More>>

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.tesseratherapeutics.com
55 Cambridge Parkway Suite 800E
Cambridge, MA USA 02142
Phone: 617.868.1888

Name	Title	Contact Details
Jacob Rubens	Chief Innovation Officer	Profile
Iain McFadyen	Chief Data Officer	Profile

Similar Companies

Hound Labs

Hound Labs combines science and technology in novel ways to improve health and wellness. The Company believes its ultra-sensitive and portable technologies will pave the way to practical and fair solutions for some of the leading public health and safety issues. In the coming month, Hound Labs will launch the HOUND® CANNABIS BREATHALYZER, which allows employers and law enforcement to identify recent cannabis in breath. Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, founded Hound Labs in 2014.

CTOs on the Move